FI920565L - Ige-receptor antikroppar. - Google Patents

Ige-receptor antikroppar. Download PDF

Info

Publication number
FI920565L
FI920565L FI920565A FI920565A FI920565L FI 920565 L FI920565 L FI 920565L FI 920565 A FI920565 A FI 920565A FI 920565 A FI920565 A FI 920565A FI 920565 L FI920565 L FI 920565L
Authority
FI
Finland
Prior art keywords
receptor antibodies
ige receptor
ige
antibodies
receptor
Prior art date
Application number
FI920565A
Other languages
English (en)
Finnish (fi)
Other versions
FI920565A7 (fi
FI920565A0 (fi
Inventor
Richard Anthony Chizzonite
John Hakimi
Jarema Peter Kochan
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of FI920565A0 publication Critical patent/FI920565A0/fi
Publication of FI920565A7 publication Critical patent/FI920565A7/fi
Publication of FI920565L publication Critical patent/FI920565L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/283—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against Fc-receptors, e.g. CD16, CD32, CD64
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FI920565A 1991-02-11 1992-02-11 Ige-receptor antikroppar. FI920565L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US65393691A 1991-02-11 1991-02-11

Publications (3)

Publication Number Publication Date
FI920565A0 FI920565A0 (fi) 1992-02-11
FI920565A7 FI920565A7 (fi) 1992-08-12
FI920565L true FI920565L (fi) 1992-08-12

Family

ID=24622869

Family Applications (1)

Application Number Title Priority Date Filing Date
FI920565A FI920565L (fi) 1991-02-11 1992-02-11 Ige-receptor antikroppar.

Country Status (20)

Country Link
EP (1) EP0499112A1 (cs)
JP (1) JPH05252988A (cs)
KR (1) KR920016105A (cs)
AR (1) AR245784A1 (cs)
AU (1) AU652024B2 (cs)
BR (1) BR9200442A (cs)
CA (1) CA2059842A1 (cs)
CS (1) CS39092A3 (cs)
FI (1) FI920565L (cs)
HU (1) HUT63205A (cs)
IE (1) IE920434A1 (cs)
IL (1) IL100869A0 (cs)
IS (1) IS3813A (cs)
MX (1) MX9200526A (cs)
NO (1) NO920523L (cs)
NZ (1) NZ241552A (cs)
RO (1) RO109707B1 (cs)
UY (1) UY23374A1 (cs)
YU (1) YU13392A (cs)
ZA (1) ZA92800B (cs)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5770396A (en) * 1992-04-16 1998-06-23 The United States Of America As Represented By The Department Of Health And Human Services Isolation characterization, and use of the human beta subunit of the high affinity receptor for immunoglobulin E
ES2108566T3 (es) * 1993-12-10 1997-12-16 Genentech Inc Procedimientos para diagnosticar alergias y para seleccionar agentes terapeuticos antialergicos.
JP2952750B2 (ja) * 1995-02-23 1999-09-27 株式会社林原生物化学研究所 モノクローナル抗体
US7135458B1 (en) 1995-11-15 2006-11-14 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Interferon-γ inducing polypeptide, pharmaceutical composition thereof, monoclonal antibody thereto, and methods of use
AR008077A1 (es) * 1996-07-26 1999-12-09 Talarico Salinas Laura Beatriz Un polipeptido de fusion o una sal del mismo, su uso, un proceso para prepararlos, una composicion farmaceutica que los comprende, y un vector.
US6423512B1 (en) 1996-07-26 2002-07-23 Novartis Ag Fusion polypeptides
US6299875B1 (en) 1998-06-04 2001-10-09 Panacea Pharmaceuticals, Llc Methods to block IGE binding to cell surface receptors of mast cells
US7759133B2 (en) * 1998-12-22 2010-07-20 Alk-Abello A/S Method of detecting and/or quantifying a specific IgE antibody in a liquid sample
US20030166568A1 (en) * 2000-03-23 2003-09-04 Franz Kricek Organic compounds
WO2003008584A1 (en) * 2001-07-19 2003-01-30 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute HUMAN TYPE ANTIHUMAN IgE RECEPTOR ANTIBODY AND ANTIBODY FRAGMENT
CA2676843A1 (en) * 2007-01-29 2008-08-07 Valtion Teknillinen Tutkimuskeskus Method for producing novel ige based reagents
KR101686395B1 (ko) 2015-06-22 2016-12-15 주식회사 선일기연 Ｐｃｂ용 단자 삽입기의 삽입력 측정장치
CN105352930A (zh) * 2015-12-01 2016-02-24 深圳市绿诗源生物技术有限公司 基于amf为荧光素标记物的双酚a荧光偏振免疫分析检测方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4962035A (en) * 1987-12-01 1990-10-09 President And Fellows Of Harvard College DNA encoding IgE receptor alpha-subunit or fragment thereof

Also Published As

Publication number Publication date
FI920565A7 (fi) 1992-08-12
KR920016105A (ko) 1992-09-24
HUT63205A (en) 1993-07-28
NO920523D0 (no) 1992-02-10
AU1080292A (en) 1992-08-13
MX9200526A (es) 1992-08-01
CA2059842A1 (en) 1992-08-12
AU652024B2 (en) 1994-08-11
YU13392A (sh) 1995-01-31
NZ241552A (en) 1994-03-25
JPH05252988A (ja) 1993-10-05
HU9200293D0 (en) 1992-04-28
AR245784A1 (es) 1994-02-28
IL100869A0 (en) 1992-11-15
FI920565A0 (fi) 1992-02-11
BR9200442A (pt) 1992-10-20
ZA92800B (en) 1992-10-28
IS3813A (is) 1992-08-12
UY23374A1 (es) 1992-07-30
EP0499112A1 (en) 1992-08-19
CS39092A3 (en) 1992-09-16
IE920434A1 (en) 1992-08-12
RO109707B1 (ro) 1995-05-30
NO920523L (no) 1992-08-12

Similar Documents

Publication Publication Date Title
DE68914244D1 (de) Monoklonaler Antikörper.
NO924279D0 (no) Lyofilisert, monoklonalt antistoffpreparat
DK666389A (da) Monoklonalt antistof
FI930580L (fi) Tri- och tetravalensiska monopecifika antigen bindande proteiner
DE69232604D1 (de) Antikörperkonstrukte
CY2006001I2 (el) Ανθρωποποιημενο heregulin αντισωμα
DE69018801D1 (de) Chimärischer anti-cae-antikörper.
EP0587067A3 (en) Electrophotographic device.
DE3879452D1 (de) Chimaere antikoerper.
FI960567L (fi) Monoklonaalinen vasta-aine, joka indusoi apoptoosin
FI922143A7 (fi) Muscarinreceptorantagonister.
DE3854502D1 (de) Gegen hiv-antigene spezifischer monoklonaler antikörper.
FI910973A7 (fi) Tuumorinekroositekijäreseptorin vasta-aine
DE3885355D1 (de) Monoklonale Antikörper.
FI920565L (fi) Ige-receptor antikroppar.
DE69217826D1 (de) Elektrophotographischer Rezeptor
NO894444D0 (no) Anti-fucosylceramid monoklonalt antistoff.
DE69206522D1 (de) Vibrator.
NO890116D0 (no) Monoklonale antistoffer.
FI934963A7 (fi) CTAA 81AV78, monoklonaalisen 81AV78-humaanivasta-aineen tunnistama ant igeeni
DK474189A (da) Monoklonalt antistof
MX9202642A (es) Anticuerpos monoclonales y antigeno para melanoma humano.
ITMI910491A0 (it) Immonotossina da anticorpi monoclonali anti-cds
DE69023717D1 (de) Monoklonaler Antikörper.
IT8821702A0 (it) Nuovo anticorpo monoclonale.

Legal Events

Date Code Title Description
FD Application lapsed